{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:15:43Z","timestamp":1785575743684,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:00:00Z","timestamp":1574467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:00:00Z","timestamp":1574467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10147-019-01581-0","type":"journal-article","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T06:02:52Z","timestamp":1574488972000},"page":"698-704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2404-6209","authenticated-orcid":false,"given":"Askin","family":"Eroglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmi Gokhan","family":"Ekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rauf Taner","family":"Divrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,23]]},"reference":[{"key":"1581_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, B\u00f6hle A, Burger M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447","journal-title":"Eur Urol"},{"key":"1581_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87","journal-title":"CA Cancer J Clin"},{"key":"1581_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","volume":"69","author":"S Cambier","year":"2016","unstructured":"Cambier S, Sylvester RJ, Collette L et al (2016) EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1\u20133 years of maintenance Bacillus Calmette-Gu\u00e9rin. Eur Urol 69:60","journal-title":"Eur Urol"},{"key":"1581_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:465","journal-title":"Eur Urol"},{"key":"1581_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000355358","volume":"92","author":"V Soukup","year":"2014","unstructured":"Soukup V, Duskova J, Pesl M et al (2014) The prognostic value of T1 bladder cancer substaging: a single institution retrospective study. Urol Int 92:150","journal-title":"Urol Int"},{"key":"1581_CR6","doi-asserted-by":"publisher","first-page":"e2625","DOI":"10.1097\/MD.0000000000002625","volume":"95","author":"Z Shen","year":"2016","unstructured":"Shen Z, Xie L, Chen T et al (2016) Risk Factors predictive of recurrence and progression for patients who suffered initial recurrence after transurethral resection of stage pT1 bladder tumor in Chinese population: a retrospective study. Med (Baltim) 95:e2625","journal-title":"Med (Baltim)"},{"key":"1581_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","volume":"58","author":"RT Divrik","year":"2010","unstructured":"Divrik RT, Sahin AF, Yildirim U et al (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58:185","journal-title":"Eur Urol"},{"key":"1581_CR8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0022-5347(05)01002-5","volume":"175","author":"RT Divrik","year":"2006","unstructured":"Divrik RT, Yildirim U, Zorlu F et al (2006) The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 175:1641","journal-title":"J Urol"},{"key":"1581_CR9","unstructured":"Eble JN, Sauter G, Epstein JI et al (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon"},{"key":"1581_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.6004\/jnccn.2015.0123","volume":"13","author":"HW Herr","year":"2015","unstructured":"Herr HW (2015) Role of repeat resection in non-muscle-invasive bladder cancer. J Natl Compr Canc Netw 13:1041","journal-title":"J Natl Compr Canc Netw"},{"key":"1581_CR11","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0022-5347(05)00689-0","volume":"175","author":"T Divrik","year":"2006","unstructured":"Divrik T, Yildirim U, Eroglu A et al (2006) Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer? J Urol 175:1258","journal-title":"J Urol"},{"key":"1581_CR12","first-page":"27","volume":"12","author":"J Rigaud","year":"2002","unstructured":"Rigaud J, Karam G, Braud G et al (2002) Value of second endoscopic resection in stage T1 bladder tumors. Prog Urol 12:27","journal-title":"Prog Urol"},{"key":"1581_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000075961","volume":"72","author":"MA Zurkirchen","year":"2004","unstructured":"Zurkirchen MA, Sulser T, Gaspert A et al (2004) Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologist. Urol Int 72:99","journal-title":"Urol Int"},{"key":"1581_CR14","unstructured":"Vogeli TA, Grimm M-O, Simon X et al (2002) Prospective study to assess repeat transurethral resection in superficial bladder cancer. Urologe A 41:470"},{"key":"1581_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0090-4295(01)01522-9","volume":"59","author":"L Schips","year":"2002","unstructured":"Schips L, Augustin H, Zigeuner RE et al (2002) Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 59:220","journal-title":"Urology"},{"key":"1581_CR16","doi-asserted-by":"crossref","unstructured":"Jakse G, Algaba F, Malmstrom PU et al (2004) A second-look TUR in T1 transitional cell carcinoma: why? Eur Urol 45:539","DOI":"10.1016\/j.eururo.2003.12.016"},{"key":"1581_CR17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","volume":"73","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Foerster B, Catto JWF et al (2018) Repeat transurethral resection in non\u2013muscle-invasive bladder cancer: a systematic review. Eur Urol 73:925","journal-title":"Eur Urol"},{"key":"1581_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.euf.2016.12.011","volume":"4","author":"A Naselli","year":"2018","unstructured":"Naselli A, Hurle R, Paparella S et al (2018) Role of restaging transurethral resection for T1 non-muscle invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Focus 4:558","journal-title":"Eur Urol Focus"},{"key":"1581_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/bju.13354","volume":"118","author":"P Gontero","year":"2016","unstructured":"Gontero P, Sylvester R, Pisano F et al (2016) The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade\/Grade 3 bladder cancer treated with bacille Calmette-Gu\u00e9rin. BJU Int 118:44","journal-title":"BJU Int"},{"key":"1581_CR20","first-page":"603","volume":"35","author":"F Audenet","year":"2017","unstructured":"Audenet F, Retinger C, Chien C et al (2017) Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion? Urol Oncol Semin Orig Investig 35:603","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"1581_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/bju.13265","volume":"117","author":"R Gendy","year":"2016","unstructured":"Gendy R, Delprado W, Brenner P et al (2016) Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series. BJU Int 117:54","journal-title":"BJU Int"},{"key":"1581_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.juro.2013.08.022","volume":"191","author":"JP Sfakianos","year":"2014","unstructured":"Sfakianos JP, Kim PH, Hakimi AA et al (2014) The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Gu\u00e9rin. J Urol 191:341","journal-title":"J Urol"},{"key":"1581_CR23","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1089\/end.2011.0576","volume":"26","author":"W Kim","year":"2012","unstructured":"Kim W, Song C, Park S et al (2012) Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor. J Endourol 26:1059","journal-title":"J Endourol"},{"key":"1581_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00005392-200102000-00011","volume":"165","author":"D Mack","year":"2001","unstructured":"Mack D, H\u00f6ltl W, Bassi P et al (2001) The ablative effect of quarter dose bacillus Calmette-Guerin on a papillary marker lesion of the bladder. J Urol 165:401","journal-title":"J Urol"},{"key":"1581_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/0974-7796.163798","volume":"8","author":"K Hashine","year":"2016","unstructured":"Hashine K, Ide T, Nakashima T et al (2016) Results of second transurethral resection for high-grade T1 bladder cancer. Urol Ann 8:10","journal-title":"Urol Ann"},{"key":"1581_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-016-0126-x","volume":"16","author":"K Iida","year":"2016","unstructured":"Iida K, Naiki T, Kawai N et al (2016) Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer. BMC Urol 16:1","journal-title":"BMC Urol"},{"key":"1581_CR27","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1097\/01.ju.0000181799.81119.fc","volume":"174","author":"HW Herr","year":"2005","unstructured":"Herr HW (2005) Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174:2134","journal-title":"J Urol"},{"key":"1581_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.acuro.2014.01.001","volume":"38","author":"JC Angulo","year":"2014","unstructured":"Angulo JC, Palou J, Garc\u00eda-Tello A et al (2014) Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Gu\u00e9rin. Actas Urol Esp 38:164","journal-title":"Actas Urol Esp"},{"key":"1581_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/S0266462310001364","volume":"27","author":"G Mowatt","year":"2011","unstructured":"Mowatt G, N\u2019Dow J, Vale L et al (2011) Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis. Int J Technol Assess Health Care 27:3","journal-title":"Int J Technol Assess Health Care"},{"key":"1581_CR30","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","volume":"64","author":"M Burger","year":"2013","unstructured":"Burger M, Grossman HB, Droller M et al (2013) Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol 64:846","journal-title":"Eur Urol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-019-01581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-019-01581-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-019-01581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T00:40:47Z","timestamp":1606005647000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-019-01581-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,23]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1581"],"URL":"https:\/\/doi.org\/10.1007\/s10147-019-01581-0","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,23]]},"assertion":[{"value":"19 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}